UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 821

Sortiert nach

Shorter durations and lower doses of peginterferon alfa‐2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C

Hepatology (Baltimore, Md.), 2011-11, Vol.54 (5), p.1591-1599

2011

Volltextzugriff (PDF)

Systematic review: cessation of long‐term nucleos(t)ide analogue therapy in patients with hepatitis B e antigen‐negative chronic hepatitis B

Alimentary pharmacology & therapeutics, 2015-08, Vol.42 (3), p.243-257

2015

Volltextzugriff (PDF)

Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B

Journal of viral hepatitis, 2013-04, Vol.20 (4), p.e37-e46

2013

Volltextzugriff (PDF)

Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion

Journal of viral hepatitis, 2007-03, Vol.14 (3), p.147-152

2007

Volltextzugriff (PDF)

Letter: nucleos(t)ide analogues are good, but not sufficient for hepatitis B virus clearance – author's reply

Alimentary pharmacology & therapeutics, 2016-03, Vol.43 (5), p.655-656

Liaw, Y.‐F.

2016

Volltextzugriff (PDF)

Great and rapid HBsAg decline in patients with on‐treatment hepatitis flare in early phase of potent antiviral therapy

Journal of viral hepatitis, 2018-04, Vol.25 (4), p.421-428

2018

Volltextzugriff (PDF)

Letter: lessons from the ‘real‐world’ entecavir therapy in chronic hepatitis B patients

Alimentary pharmacology & therapeutics, 2016-04, Vol.43 (7), p.846-847

2016

Volltextzugriff (PDF)

Serial HBV DNA levels in patients with persistently normal transaminase over 10 years following spontaneous HBeAg seroconversion

Journal of viral hepatitis, 2012-02, Vol.19 (2), p.138-146

2012

Volltextzugriff (PDF)

Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection?

International Journal of Obesity, 2007-05, Vol.31 (5), p.871-875

2007

Volltextzugriff (PDF)

Basal core promoter mutation is associated with progression to cirrhosis rather than hepatocellular carcinoma in chronic hepatitis B virus infection

British journal of cancer, 2012-12, Vol.107 (12), p.2010-2015

2012

Volltextzugriff (PDF)

Therapy of chronic hepatitis B: current challenges and opportunities

Journal of viral hepatitis, 2002-11, Vol.9 (6), p.393-399

Liaw, Y.-F.

2002

Volltextzugriff (PDF)

Sustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1386‐patient study from Taiwan

Alimentary Pharmacology and Therapeutics, 2007-05, Vol.25 (9), p.1029-1037

2007

Volltextzugriff (PDF)

Identity of a novel swine hepatitis E virus in Taiwan forming a monophyletic group with Taiwan isolates of human hepatitis E virus

Journal of Clinical Microbiology, 1999-12, Vol.37 (12), p.3828-3834

1999

Volltextzugriff (PDF)

Rumpel-Leede phenomenon in a diabetes mellitus patient

QJM : An International Journal of Medicine, 2015-08, Vol.108 (8), p.671-672

2015

Volltextzugriff (PDF)

Genome-wide hypomethylation in hepatocellular carcinogenesis

Cancer research (Chicago, Ill.), 2001-05, Vol.61 (10), p.4238-4243

2001

Volltextzugriff (PDF)

Hormonal Markers and Hepatitis B Virus-Related Hepatocellular Carcinoma Risk: a Nested Case–Control Study Among Men

JNCI : Journal of the National Cancer Institute, 2001-11, Vol.93 (21), p.1644-1651

2001

Volltextzugriff (PDF)

Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy

Hepatology (Baltimore, Md.), 1999-08, Vol.30 (2), p.567-572

1999

Volltextzugriff (PDF)

Prospective Study of Hepatocellular Carcinoma and Liver Cirrhosis in Asymptomatic Chronic Hepatitis B Virus Carriers

American journal of epidemiology, 1997-06, Vol.145 (11), p.1039-1047

1997

Volltextzugriff (PDF)

Botryomycosis presenting as nasal cutaneous fistulas caused by Prevotella melaninogenica

Clinical and experimental dermatology, 2012-07, Vol.37 (5), p.501-504

2012

Volltextzugriff (PDF)

Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma

JNCI : Journal of the National Cancer Institute, 2008-08, Vol.100 (16), p.1134-1143

2008

Volltextzugriff (PDF)

Plasma Selenium Levels and Risk of Hepatocellular Carcinoma among Men with Chronic Hepatitis Virus Infection

American journal of epidemiology, 1999-08, Vol.150 (4), p.367-374

1999

Volltextzugriff (PDF)

Long‐term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

Hepatology (Baltimore, Md.), 1999-03, Vol.29 (3), p.971-975

1999

Volltextzugriff (PDF)

Switching to adefovir monotherapy after emergence of lamivudine-resistant mutations in patients with liver cirrhosis

Journal of viral hepatitis, 2006-04, Vol.13 (4), p.250-255

2006

Volltextzugriff (PDF)

Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma

Gut, 2014-10, Vol.63 (10), p.1648-1657

2014

Volltextzugriff (PDF)

Clinical outcomes after interruption of entecavir therapy in HBeAg‐negative chronic hepatitis B patients with compensated cirrhosis

Alimentary pharmacology & therapeutics, 2015-11, Vol.42 (10), p.1182-1191

2015

Volltextzugriff (PDF)

1 – 25 von 821

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(684)
Mit Volltextzugriff
(641)

Publikationsform

Sprache

Englisch
(760)
Japanisch
(105)
Chinesisch
(56)
Deutsch
(3)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(543)
Humans
(478)
Life Sciences & Biomedicine
(399)
Biological And Medical Sciences
(307)
Male
(307)
Medical Sciences
(285)
Female
(271)
Adult
(262)
Middle Aged
(245)
Gastroenterology & Hepatology
(176)
Infectious Diseases
(146)
Aged
(141)
Viral Diseases
(118)
Human Viral Diseases
(115)
Viral Hepatitis
(110)
Technology
(98)
Hepatitis B Virus
(88)
Gastroenterology. Liver. Pancreas. Abdomen
(86)
Physical Sciences
(86)
Adolescent
(82)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Shorter durations and lower doses of peginterferon alfa‐2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C

Systematic review: cessation of long‐term nucleos(t)ide analogue therapy in patients with hepatitis B e antigen‐negative chronic hepatitis B

Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B

Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion

Letter: nucleos(t)ide analogues are good, but not sufficient for hepatitis B virus clearance – author's reply

Great and rapid HBsAg decline in patients with on‐treatment hepatitis flare in early phase of potent antiviral therapy

Letter: lessons from the ‘real‐world’ entecavir therapy in chronic hepatitis B patients

Serial HBV DNA levels in patients with persistently normal transaminase over 10 years following spontaneous HBeAg seroconversion

Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection?

Basal core promoter mutation is associated with progression to cirrhosis rather than hepatocellular carcinoma in chronic hepatitis B virus infection

Therapy of chronic hepatitis B: current challenges and opportunities

Sustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1386‐patient study from Taiwan

Identity of a novel swine hepatitis E virus in Taiwan forming a monophyletic group with Taiwan isolates of human hepatitis E virus

Rumpel-Leede phenomenon in a diabetes mellitus patient

Genome-wide hypomethylation in hepatocellular carcinogenesis

Hormonal Markers and Hepatitis B Virus-Related Hepatocellular Carcinoma Risk: a Nested Case–Control Study Among Men

Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy

Prospective Study of Hepatocellular Carcinoma and Liver Cirrhosis in Asymptomatic Chronic Hepatitis B Virus Carriers

Botryomycosis presenting as nasal cutaneous fistulas caused by Prevotella melaninogenica

Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma

Plasma Selenium Levels and Risk of Hepatocellular Carcinoma among Men with Chronic Hepatitis Virus Infection

Long‐term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

Switching to adefovir monotherapy after emergence of lamivudine-resistant mutations in patients with liver cirrhosis

Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma

Clinical outcomes after interruption of entecavir therapy in HBeAg‐negative chronic hepatitis B patients with compensated cirrhosis

Suchergebnisse filtern